Boehringer Ingelheim Nintedanib gets USFDA Breakthrough Therapy Designation for chronic ILDs Medical Dialogues Bureau13 Oct 2019 9:22 AM ISTNew Delhi: Boehringer Ingelheim announced recently that the U.S. Food and Drug Administration (USFDA) granted Breakthrough Therapy Designation to...
Pfizer, Akcea enter licensing agreement for investigational antisense therapy AKCEA-ANGPTL3-LRx Medical Dialogues Bureau13 Oct 2019 9:15 AM ISTNew Delhi: Pfizer Inc. and Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc, recently announced that the companies...
Gilead, Galapagos reports efficacy, safety results on rheumatoid arthritis drug Filgotinib Farhat Nasim13 Oct 2019 9:00 AM ISTNew Delhi: Gilead Sciences, Inc. and Galapagos NV recently announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of...
Cadila Healthcare largest API manufacturing site clears USFDA inspection Medical Dialogues Bureau12 Oct 2019 11:41 AM ISTThe US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
Eli Lilly migraine drug Lasmiditan wins USFDA approval Medical Dialogues Bureau12 Oct 2019 10:00 AM ISTEli Lilly acquired Reyvow, formerly called lasmiditan, in a deal here worth about $960 million when it bought CoLucid Pharmaceuticals Inc in early...
GSK collaborates with Lyell Immunopharma on cancer cell therapies Medical Dialogues Bureau12 Oct 2019 9:15 AM ISTCombining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
OxyContin maker Purdue Pharma seeks to halt opioid lawsuits Farhat Nasim12 Oct 2019 9:00 AM ISTNew Delhi: OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 10:00 AM IST"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
Biocon arm signs licensing agreement with Evotec for biosimilar asset Medical Dialogues Bureau11 Oct 2019 9:45 AM ISTThrough this in-licensing deal, Biocon Biologics has expanded its current therapeutic basket of biosimilars going beyond diabetes, oncology and...
Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis Farhat Nasim11 Oct 2019 9:30 AM ISTNew Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
Bayer inks deals with 11 startups under G4A to develop new digital health solutions Farhat Nasim11 Oct 2019 9:25 AM ISTNew Delhi: Bayer announced recently that the company has signed collaboration agreements with eleven digital health startups. As part of the program,...
Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility Medical Dialogues Bureau11 Oct 2019 9:15 AM ISTTorrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
